These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 20038365

  • 21. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
    Transplantation; 1998 Jan 27; 65(2):235-41. PubMed ID: 9458021
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of mycophenolate mofetil in severe mucocutaneous lichen planus: a retrospective review of 10 patients.
    Wee JS, Shirlaw PJ, Challacombe SJ, Setterfield JF.
    Br J Dermatol; 2012 Jul 27; 167(1):36-43. PubMed ID: 22309851
    [Abstract] [Full Text] [Related]

  • 23. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis.
    Phan K, Smith SD.
    J Dermatolog Treat; 2020 Dec 27; 31(8):810-814. PubMed ID: 31294617
    [Abstract] [Full Text] [Related]

  • 24. An analysis of the dermatological uses of mycophenolate mofetil in a tertiary hospital.
    George L, Hamann I, Chen K, Choi J, Fernandez-Peñas P.
    J Dermatolog Treat; 2015 Feb 27; 26(1):63-6. PubMed ID: 24286467
    [Abstract] [Full Text] [Related]

  • 25. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Clin Transplant; 1996 Feb 27; 10(1 Pt 2):131-5. PubMed ID: 8680050
    [Abstract] [Full Text] [Related]

  • 26. Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients.
    Budde K, Glander P, Diekmann F, Dragun D, Waiser J, Fritsche L, Neumayer HH.
    Transplant Proc; 2004 Mar 27; 36(2 Suppl):524S-527S. PubMed ID: 15041401
    [Abstract] [Full Text] [Related]

  • 27. Mycophenolate mofetil as a treatment for urticarial dermatitis.
    Chaptini C, Sidhu S.
    Australas J Dermatol; 2014 Nov 27; 55(4):275-8. PubMed ID: 25178716
    [Abstract] [Full Text] [Related]

  • 28. Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.
    Fujinaga S, Ohtomo Y, Hirano D, Nishizaki N, Someya T, Ohtsuka Y, Kaneko K, Shimizu T.
    Clin Nephrol; 2009 Oct 27; 72(4):268-73. PubMed ID: 19825332
    [Abstract] [Full Text] [Related]

  • 29. Systemic therapy of childhood atopic dermatitis.
    Slater NA, Morrell DS.
    Clin Dermatol; 2015 Oct 27; 33(3):289-99. PubMed ID: 25889129
    [Abstract] [Full Text] [Related]

  • 30. Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
    Mertens JS, Marsman D, van de Kerkhof PC, Hoppenreijs EP, Knaapen HK, Radstake TR, de Jong EM, Seyger MM.
    Acta Derm Venereol; 2016 May 27; 96(4):510-3. PubMed ID: 26582717
    [Abstract] [Full Text] [Related]

  • 31. [A prospective multicenter clinical control trial on treatment of refractory nephrotic syndrome with mycophenolate mofetil in children].
    Yi ZW, Wu XC, Xu H, Zhou LJ, Wu YB, Feng SP, Zhou JH, Yang Q, Zhu GH, Liu AM, Wei MJ, Yu L, Zeng ZF.
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Oct 27; 10(5):575-8. PubMed ID: 18947472
    [Abstract] [Full Text] [Related]

  • 32. Systemic therapy of atopic dermatitis in children and adults.
    Simon D.
    Curr Probl Dermatol; 2011 Oct 27; 41():156-164. PubMed ID: 21576956
    [Abstract] [Full Text] [Related]

  • 33. Mycophenolate mofetil (MMF) versus azathioprine (AZA) in pancreas transplantation: a single-center experience.
    Rigotti P, Cadrobbi R, Baldan N, Sarzo G, Parise P, Furian L, Marchini F, Ancona E.
    Clin Nephrol; 2000 Apr 27; 53(4):suppl 52-4. PubMed ID: 10809437
    [Abstract] [Full Text] [Related]

  • 34. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B, Chen N, Lin Y, Ren H, Zhang W, Wang W, Pan X, Yu H.
    Nephrol Dial Transplant; 2007 Jul 27; 22(7):1933-42. PubMed ID: 17405792
    [Abstract] [Full Text] [Related]

  • 35. Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patients.
    Jackson JM, Fowler JF, Callen JP, Lorenz DJ.
    J Drugs Dermatol; 2010 Apr 27; 9(4):356-62. PubMed ID: 20514793
    [Abstract] [Full Text] [Related]

  • 36. Long-term results of mycophenolate mofetil as part of immunosuppressive induction therapy after liver transplantation.
    Langrehr JM, Klupp J, Glanemann M, Junge G, Pfitzmann R, Bahra M, Radtke C, Neumann U, Neuhaus R, Neuhaus P.
    Clin Transplant; 2006 Apr 27; 20(3):272-83. PubMed ID: 16824141
    [Abstract] [Full Text] [Related]

  • 37. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar 27; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis.
    Koukoulaki M, Jayne DR.
    Nephron Clin Pract; 2006 Mar 27; 102(3-4):c100-7. PubMed ID: 16286784
    [Abstract] [Full Text] [Related]

  • 39. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W.
    Transplantation; 2007 Feb 27; 83(4):417-24. PubMed ID: 17318074
    [Abstract] [Full Text] [Related]

  • 40. Mycophenolate mofetil therapy for children with intractable nephrotic syndrome.
    Okada M, Sugimoto K, Yagi K, Yanagida H, Tabata N, Takemura T.
    Pediatr Int; 2007 Dec 27; 49(6):933-7. PubMed ID: 18045300
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.